Récepteur cannabinoïde
Les récepteurs cannabinoïdes sont des GPCR qui médiatisent les effets des cannabinoïdes endogènes (endocannabinoïdes) et des phytocannabinoïdes, tels que ceux trouvés dans le cannabis. Les deux principaux types de récepteurs cannabinoïdes, CB1 et CB2, sont impliqués dans la régulation d'une large gamme de processus physiologiques, y compris la perception de la douleur, l'appétit, l'humeur et la fonction immunitaire. Les modulateurs des récepteurs cannabinoïdes ont un potentiel thérapeutique dans le traitement de conditions telles que la douleur chronique, l'épilepsie et la sclérose en plaques. Chez CymitQuimica, nous offrons une large gamme de modulateurs de récepteurs cannabinoïdes de haute qualité pour soutenir vos recherches en neuropharmacologie, gestion de la douleur et immunologie.
218 produits trouvés pour "Récepteur cannabinoïde".
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
CB1/2 agonist 1
Potent CB1/2 agonist 1; crosses blood-brain barrier; anti-inflammatory, analgesic; for multiple sclerosis research.Formule :C21H24BrFN2O2Couleur et forme :SolidMasse moléculaire :435.33MDA7
CAS :MDA7 is a selective agonist of the cannabinoid receptor 2 (CB2), demonstrating an EC50 of 128 nM in human CB2 receptors and 67.4 nM in rat CB2 receptors. The compound exhibits good affinity for CB2 receptors, with Ki values of 422 nM for humans and 238 nM for rats. In rat models, MDA7 shows analgesic activity.Formule :C22H25NO2Couleur et forme :SolidMasse moléculaire :335.439MDMB-FUBICA
CAS :MDMB-FUBICA is a potent agonist of the cannabinoid receptors and exhibits psychoactive properties. It can be utilized in e-cigarettes.Formule :C23H25FN2O3Couleur et forme :SolidMasse moléculaire :396.455Taranabant
CAS :Taranabant: potent CB1 receptor inverse agonist; inhibits agonists with 0.13 nM Ki in vitro.Formule :C27H25ClF3N3O2Degré de pureté :99.06% - 99.06%Couleur et forme :SolidMasse moléculaire :515.96CBR Agonist-1
CBR Agonist-1 targets CB1R and CB2R with Ki of 0.18 μM and 1.22 μM, useful for studying cannabinoid-related diseases.Formule :C27H27FN4OCouleur et forme :SolidMasse moléculaire :442.53CB1/2 receptor-1
CAS :CB1/2 receptor-1 (compound 5.3) serves as an agonist for CB1/2 receptors and is utilized in angiogenesis research.Formule :C33H48O2Couleur et forme :SolidMasse moléculaire :476.731'-Naphthoyl-2-methylindole
CAS :1'-Naphthoyl-2-methylindole (Compound 88) acts as a cannabinoid mimic and an inhibitor of Win 55212-2, displaying a 34% inhibition of [3H]Win 55212-2 binding to cannabinoid receptors at a concentration of 3 μM.Formule :C20H15NOCouleur et forme :SolidMasse moléculaire :285.34MDA77
CAS :MDA77 is a CB2 agonist with an EC50 value of 5.82 nM and exhibits no activity towards CB1.Formule :C21H23N3O3Couleur et forme :SolidMasse moléculaire :365.43BNS808
CAS :BNS808 is an orally active, selective CB1R antagonist with an IC50 of 0.8 nM, demonstrating significant selectivity for CB2R and minimal brain penetration. It is being studied for the treatment of obesity and related metabolic complications, such as metabolic dysfunction-associated steatotic liver disease (MASLD). BNS808 reduces drug exposure to the central nervous system, enhancing safety, and minimizes drug interactions through high plasma protein binding.Formule :C25H20Cl3N3O3SCouleur et forme :SolidMasse moléculaire :548.869AB-FUBINACA 3-fluorobenzyl isomer
CAS :AB-FUBINACA 3-fluorobenzyl isomer is a synthetic cannabinoid and an indazole derivative, exhibiting high affinity for central CB1 receptors (Ki= 0.9 nM) and possessing anticonvulsant activity.Formule :C20H21FN4O2Couleur et forme :SolidMasse moléculaire :368.41GAT564
GAT564, an allosteric CB1R modulator, shows EC50s of 87 nM (cAMP) & 320 nM (β-arrestin2) and lowers IOP effectively in glaucoma mice.Formule :C20H16N2O2SCouleur et forme :SolidMasse moléculaire :348.42Cannabigerovarin
CAS :Cannabigerovarin (CBGV) is a compound categorized as a phytocannabinoid.Formule :C19H28O2Masse moléculaire :288.42Bzo-poxizid
CAS :Bzo-poxizid is a synthetic cannabinoid and a psychoactive substance.Formule :C20H21N3O2Couleur et forme :SolidMasse moléculaire :335.40Virodhamine hydrochloride
CAS :Virodhamine (hydrochloride) acts as a partial agonist of the cannabinoid CB1 receptor and a full agonist of the cannabinoid CB2 receptor.Formule :C22H38ClNO2Masse moléculaire :384.00Ac-Atovaquone
CAS :Ac-Atovaquone, an ester-acetylated derivative of atovaquone, acts as a potent inhibitor of cytochrome bc1 (cytochrome bc1). This compound shows potential for use in malaria research.Formule :C24H21ClO4Couleur et forme :SolidMasse moléculaire :408.87HU 433
CAS :HU 433, a synthetic cannabinoid, acts as a CB2 receptor agonist and is an enantiomer of HU 308. It provides anti-inflammatory and neuroprotective effects by binding to the CB2 receptor, primarily found on immune cells, thereby modulating immune responses and inflammation. Additionally, HU 433 influences microglial signaling pathways, particularly LPS and IFNγ-mediated routes, affecting the phosphorylation of MAPKs, including ERK1/2, JNK, p38, and Akt. This compound is valuable in researching neuroinflammation and retinal diseases.Formule :C27H42O3Couleur et forme :SolidMasse moléculaire :414.62CB2 receptor antagonist 1
CAS :Compound 29 is a potent, CB2-selective antagonist/reverse agonist. Derivatives 23 & 24 offer antinociception; 24 activates cannabinoid/TRPV1 receptors.Formule :C28H47NO3Couleur et forme :SolidMasse moléculaire :445.68BAY 38-7271
CAS :BAY 38-7271: potent neuroprotective, selective CB1/CB2 agonist, Ki of 1.85 nM (CB1) & 5.96 nM (CB2).Formule :C20H21F3O5SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :430.44
